Compound class:
Synthetic organic
Comment: OPS-2071 is a fluoroquinolone antibacterial compound, with broad-spectrum activity against both Gram-positive and Gram-negative bacteria [2]. It is a clinical candidate being developed by Otsuka Pharmaceutical (Tokyo, Japan) as a treatment for intestinal infections, particularly those caused by Clostridioides difficile. Functionally, it is a type II DNA topoisomerase inhibitor with similar activity against DNA gyrase and DNA topoisomerase 4 [1].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
7-(6-amino-5-cyanopyridin-3-yl)-1-cyclopropyl-6-fluoro-8-methyl-4-oxoquinoline-3-carboxylic acid |
Database Links | |
Specialist databases | |
Antibiotic DB | OPS-2071 |
Other databases | |
CAS Registry No. | 1426216-93-4 (source: Scifinder) |
GtoPdb PubChem SID | 491299979 |
PubChem CID | 71289877 |
Search Google for chemical match using the InChIKey | DTSKYQBTFHFYAZ-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | DTSKYQBTFHFYAZ |
UniChem Compound Search for chemical match using the InChIKey | DTSKYQBTFHFYAZ-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | DTSKYQBTFHFYAZ-UHFFFAOYSA-N |